Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study
International Journal of Urology · 2023
DOI: 10.1111/iju.15147 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Urology, 2023. Verfasst von Toshiki Kijima. Beteiligte Einrichtung: Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan.
ORCID-Profile: Toshiki Kijima
Zitieren
APA
Kijima, T. (2023). Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study. International Journal of Urology. https://doi.org/10.1111/iju.15147
Vancouver
Kijima T. Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study. International Journal of Urology. 2023. doi:10.1111/iju.15147
BibTeX
@article{Kijima2023,
author = {Kijima, Toshiki},
title = {Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study},
journal = {International Journal of Urology},
year = {2023},
doi = {10.1111/iju.15147}
}
EUVIMED